Lizbeth Anahí Portillo-Torres, José Mercado-Monroy, Aurea Bernardino-Nicanor, Carlos Alberto Gómez-Aldapa, Leopoldo González-Cruz, Esmeralda Rangel-Vargas, Javier Castro-Rosas
{"title":"Antibacterial Activity of Hibiscus Acid Alone and Combined with Chloramphenicol in CD-1 Mice Infected with Multidrug-Resistant Enterohemorrhagic <i>Escherichia coli</i> and <i>Salmonella</i> Typhimurium.","authors":"Lizbeth Anahí Portillo-Torres, José Mercado-Monroy, Aurea Bernardino-Nicanor, Carlos Alberto Gómez-Aldapa, Leopoldo González-Cruz, Esmeralda Rangel-Vargas, Javier Castro-Rosas","doi":"10.1177/1096620X251384555","DOIUrl":"10.1177/1096620X251384555","url":null,"abstract":"<p><p>The antibacterial effect of chloramphenicol, hibiscus acid, and a mixture of hibiscus acid and chloramphenicol against antibiotic-resistant enterohemorrhagic <i>Escherichia coli</i> (EHEC) and <i>Salmonella</i> Typhimurium (ST) was determined in Caesarean-Derived (CD)-1 mice. Hibiscus acid was isolated from <i>Hibiscus sabdariffa</i> calyces. The minimum inhibitory concentration (MIC) and the minimum bactericidal concentration (MBC) of chloramphenicol (CH), hibiscus acid (HA), and mixtures of HA/CH were determined for EHEC and ST. 11 groups of six mice each were formed. Four groups were inoculated orally with 4 log<sub>10</sub> Colony forming units (CFU) of ST, four groups were inoculated with 4 log<sub>10</sub> CFU of EHEC, and the remaining three groups were not inoculated. Six hours post inoculation, the mice in some groups received, via the oral route, solutions of hibiscus acid (7 mg/mL), chloramphenicol (82 µg/mL), a mixture of HA/CH (5.7 mg/mL HA and 4 µg/mL CH), or isotonic saline solution. The MIC and MBC values were between 7 and 5 mg/mL for hibiscus acid, between 17.6 and 82 µg/mL for chloramphenicol, and between 4.2 mg/mL/0.3 µg/mL and 5.7 mg/mL/0.4 µg/mL (concentration of hibiscus acid/concentration of chloramphenicol) or HA/CH. EHEC and ST were not detected in the feces of mice that were administered hibiscus acid alone or in mixture with chloramphenicol. By contrast, pathogens were isolated from the feces of untreated mice and those treated with chloramphenicol alone throughout the study.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"379-383"},"PeriodicalIF":2.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145199694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Omar Y Alcátar-Ramírez, José Alberto Mendoza-Espinoza, Mabel Fragoso-Serrano, José Antonio López-Barrera, Laura J Pérez-Flores
{"title":"Green Synthesis, Chemical Characterization, and Antiproliferative Effect of Gold Nanoparticles Using Methanolic Extracts of <i>Chrysophyllum cainito</i> L. Peels.","authors":"Omar Y Alcátar-Ramírez, José Alberto Mendoza-Espinoza, Mabel Fragoso-Serrano, José Antonio López-Barrera, Laura J Pérez-Flores","doi":"10.1177/1096620X251387594","DOIUrl":"10.1177/1096620X251387594","url":null,"abstract":"<p><p>The article's aim was thus to evaluate the antiproliferative activity of gold nanoparticles associated with the methanolic extract of <i>Chrysophyllum cainito</i> in human breast cancer cell line (MCF-7), cervical cancer tissue (HeLa), and colorectal cancer cell line (HCT-116) cancer cell lines. The methanolic extract showed the presence of polyphenols and organic acids related to anticancer properties. In relation to the gold nanoparticles functionalized with the methanolic extract of <i>C. cainito</i> peels, these nanoparticles showed significant cytotoxic activity (<i>p = .0001</i>) in the HCT-116 cell line at 72 h after exposure to these. We consider this the first contribution to the use of the methanolic extract of <i>C. cainito</i> for the green synthesis of gold nanoparticles. In conclusion, the green synthesis of gold nanoparticles associated with <i>C. cainito</i> methanolic peel extract may be an interesting option for the search for new cancer treatments.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"418-427"},"PeriodicalIF":2.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145377749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tamarixetin Improves Metabolic Dysfunction by Inhibiting the p300-Mediated Epigenetic Activation of Pyruvate Dehydrogenase Kinase 4.","authors":"Ji-Hye Song, Jangho Lee, Hyo-Jin Kim, Jae-In Lee, Yu Geon Lee, Hyo-Kyoung Choi, Jin-Taek Hwang","doi":"10.1177/1096620X261462216","DOIUrl":"https://doi.org/10.1177/1096620X261462216","url":null,"abstract":"<p><p>Excessive lipid accumulation is a hallmark of metabolic disorders which includes obesity and insulin resistance; however, effective therapeutic strategies remain limited. Tamarixetin (Tx), a naturally occurring flavonoid with diverse pharmacological properties, has not been fully characterized in the context of lipid metabolism. In this study, we explored the metabolic benefits and molecular mechanisms of Tx in a Western diet (WD)-induced obesity model. Transcriptomic profiling revealed that Tx reversed WD-induced gene expression patterns, notably suppressing <i>Pdk4</i> and inducing <i>Phlda1</i> expression. Mechanistically, docking analysis suggested that Tx interacts with the acetyl-CoA-binding region within the p300 histone acetyltransferase domain, thereby attenuating H3K9 acetylation at the Pdk4 promoter. This epigenetic inhibition of <i>Pdk4</i> led to activation of the p38/AMPK signaling cascade, upregulation of <i>PPARGC1A</i> and <i>CPT1A</i>, and enhanced insulin sensitivity <i>in vitro</i>. Collectively, our findings identify Tx as a novel epigenetic modulator that simultaneously suppresses lipogenic gene expression and restores metabolic signaling. Given its natural origin and multifaceted mode of action, Tx emerges as a promising candidate for therapeutic intervention in metabolic disorders.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"1096620X261462216"},"PeriodicalIF":1.8,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148352095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yulim Choi, Eunkyeong Kim, Sin-Hye Park, Young-Hee Kang, Sookyoung Jeon
{"title":"Ellagic Acid Attenuates MASLD by Reducing Hepatic Lipogenesis and Fibrosis in ApoE<sup>-/-</sup> Mice Fed a Cholesterol- and Cholate-Rich Paigen Diet.","authors":"Yulim Choi, Eunkyeong Kim, Sin-Hye Park, Young-Hee Kang, Sookyoung Jeon","doi":"10.1177/1096620X261438294","DOIUrl":"10.1177/1096620X261438294","url":null,"abstract":"<p><p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic liver condition with a rising global incidence, closely linked to metabolic risk factors such as dyslipidemia. Apolipoprotein E-deficient (ApoE<sup>-</sup>/<sup>-</sup>) mice fed a Paigen diet are an established model for MASLD and atherosclerosis research. This study investigated the effects of ellagic acid (EA) on MASLD progression in ApoE<sup>-</sup>/<sup>-</sup> mice fed a Paigen diet. Wild-type (WT) and ApoE<sup>-</sup>/<sup>-</sup> mice were fed a Paigen diet for 10 weeks to induce metabolic dysregulation. ApoE<sup>-</sup>/<sup>-</sup> mice were concurrently administered either EA (10 mg/kg/day orally) or no treatment. After 10 weeks, ApoE<sup>-</sup>/<sup>-</sup> mice exhibited significant hepatic lipid accumulation, confirmed by increased Oil Red O staining. EA treatment significantly reduced hepatic lipid accumulation and lipid peroxidation. Furthermore, EA administration decreased hepatic expression of lipogenic proteins, including sterol regulatory element-binding protein 1, fatty acid synthase, and CCAAT/enhancer-binding protein alpha. The hepatic fibrogenic marker, α-smooth muscle actin (α-SMA), was significantly elevated in ApoE<sup>-</sup>/<sup>-</sup> mice compared with WT, and was significantly reduced by EA. In addition, transforming growth factor-β (TGF-β) protein levels and downstream SMAD signaling components, including phosphorylated SMAD2 and total SMAD2, SMAD3, and SMAD4, were significantly attenuated by EA treatment. In conclusion, EA effectively ameliorated MASLD and hypercholesterolemia in ApoE<sup>-</sup>/<sup>-</sup> mice fed a Paigen diet. The beneficial effects of EA may be mediated through downregulating lipogenic pathways and suppressing TGF-β/SMAD signaling.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"356-363"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147574358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hee-Won Jeon, Keon-Il Yang, Sang-Joun Yu, Mi-Sun Kang, Won-Pyo Lee
{"title":"Clinical Efficacy of the Probiotic <i>Weissella cibaria</i> CMU in Adults with Gingivitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.","authors":"Hee-Won Jeon, Keon-Il Yang, Sang-Joun Yu, Mi-Sun Kang, Won-Pyo Lee","doi":"10.1177/1096620X261430298","DOIUrl":"10.1177/1096620X261430298","url":null,"abstract":"<p><p>Periodontal disease results from dysbiotic oral biofilms and the host's inflammatory response. Given the limitations of conventional therapies, this study aimed to evaluate the efficacy and safety of <i>Weissella cibaria</i> CMU (OraCMU) in improving gingival inflammation in individuals with gingivitis and incipient periodontitis. In this randomized, double-blind, placebo-controlled trial, 80 participants received either OraCMU tablets (2.0 × 10<sup>8</sup> CFU/g; <i>n</i> = 40) or placebo (<i>n</i> = 40) twice daily for 8 weeks. The primary outcome was the gingival index (GI), and secondary outcomes included bleeding on probing (BOP), probing depth, clinical attachment level, gingival recession, plaque index, inflammation-related proteins, and oral microbiota. Clinical parameters were assessed at six preselected index teeth (#16, 12, 24, 32, 36, and 44). At week 8, the probiotic group showed significantly greater reductions in GI (-0.19 ± 0.03 vs. -0.08 ± 0.04; <i>P</i> = .035) and BOP (-7.74 ± 1.54 vs. -2.82 ± 1.60; <i>P</i> = .030) compared with the placebo group. Inflammatory markers, including fibroblast growth factor-5 (<i>P</i> = .003), thymic stromal lymphopoietin (<i>P</i> = .017), and the receptor activator of nuclear factor κB ligand/osteoprotegerin ratio (<i>P</i> = .021), were significantly decreased. The levels of <i>Porphyromonas gingivalis</i> (<i>P</i> = .001), <i>Treponema denticola</i> (<i>P</i> = .005), and <i>Prevotella intermedia</i> (<i>P</i> = .046) were also significantly reduced, while <i>Weissella</i> increased (<i>P</i> < .001) in the probiotic group. Eight-week supplementation with OraCMU improved gingival health and modulated the oral microbiota and inflammatory response. No serious adverse events were reported during the study period. These findings support the potential clinical utility of OraCMU as a probiotic adjunct for managing gingivitis.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"319-331"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147433738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"<i>Corrigendum to:</i> \"Clinical Efficacy of the Probiotic Weissella cibaria CMU in Adults with Gingivitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial\".","authors":"","doi":"10.1177/1096620X261441328","DOIUrl":"10.1177/1096620X261441328","url":null,"abstract":"","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"373"},"PeriodicalIF":2.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147639145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heewoo Lee, Jeong Yoon Lee, Jae-Ho Lee, Ju-Yeon Kim, Il-Dong Choi, Jae-Jung Shim, Jae-Hwan Lee, Yoo-Hyun Lee
{"title":"Effects of <i>Lacticaseibacillus paracasei</i> HP7 Against <i>Helicobacter pylori</i>-Induced Gastric Mucosal Inflammation and Mucosal Protection.","authors":"Heewoo Lee, Jeong Yoon Lee, Jae-Ho Lee, Ju-Yeon Kim, Il-Dong Choi, Jae-Jung Shim, Jae-Hwan Lee, Yoo-Hyun Lee","doi":"10.1177/1096620X261435979","DOIUrl":"10.1177/1096620X261435979","url":null,"abstract":"<p><p><i>Helicobacter pylori</i> (<i>H. pylori</i>) is a major pathogen that colonizes the human gastric surface and induces chronic inflammation and mucosal damage, leading to various gastric diseases. This study examined the gastroprotective effects of <i>Lacticaseibacillus paracasei</i> HP7 in an <i>H. pylori</i>-infected animal model. Male C57BL/6 mice were divided into four groups: normal control, <i>H. pylori</i>-infected control (HP), <i>H. pylori</i>-infected group treated with live <i>L. paracasei</i> HP7 for 4 weeks (L-HP7), and <i>H. pylori</i>-infected group treated with heat-killed <i>L. paracasei</i> HP7 for 4 weeks (HK-HP7). The results showed that serum histamine and gastrin levels, as well as gastric mucosal inflammatory cytokine mRNA levels, including interleukin (IL)-1β, IL-6, IL-8, IL-18, interferon gamma, and tumor necrosis factor alpha, were significantly reduced in both the L-HP7 and HK-HP7 groups. Histopathological scoring of hematoxylin & eosin-stained gastric mucosal tissues also showed significant improvements in both groups. Serum anti-<i>H. pylori</i> immunoglobulin G (IgG) and CCK2R mRNA levels decreased in the L-HP7 group, whereas MUC1 mRNA levels increased. Collectively, these findings indicate that <i>L. paracasei</i> HP7, in both live and heat-killed forms, protects gastric surface epithelial and mucosal cells and alleviates inflammatory status by reducing the expression of pro-inflammatory cytokines. <i>L. paracasei</i> HP7 may serve as a promising adjunct to antibiotics in the management of <i>H. pylori</i>-associated diseases.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"332-341"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147498868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Moon Yeon Youn, Jae Kyeom Kim, Hyeonjin Park, Younglan Ban, Se Young Yu, Hee Sung Moon, Seong Jun Hong, Kangwook Lee, Hyo Ri Shin, Young Jun Kim, Eui-Cheol Shin
{"title":"Inhaling Odor-Active Compounds of <i>Osmanthus fragrans</i> Var. <i>aurantiacus</i> Suppresses Inflammation-Related Transcriptomic Signatures in LPS-Exposed SD Rat Brains: Applications of GC-MS-O and RNA Sequencing.","authors":"Moon Yeon Youn, Jae Kyeom Kim, Hyeonjin Park, Younglan Ban, Se Young Yu, Hee Sung Moon, Seong Jun Hong, Kangwook Lee, Hyo Ri Shin, Young Jun Kim, Eui-Cheol Shin","doi":"10.1177/1096620X261429015","DOIUrl":"10.1177/1096620X261429015","url":null,"abstract":"<p><p>This study investigated the effects of nasal inhalation of <i>Osmanthus fragrans</i> var. <i>aurantiacus</i> (OFA) extract in lipopolysaccharide (LPS)-challenged rats. Electronic nose analysis of the OFA extracts identified 25 volatile organic compounds. Gas chromatography-mass spectrometry-olfactometry (GC-MS-O) analysis revealed that <i>β</i>-ionone, linalool, and related derivatives are the primary odor-active compounds in the OFA extract. LPS exposure increased pro-inflammatory markers like tumor necrosis factor-alpha, caused organ hypertrophy in the liver, lungs, and spleen, and altered transcriptional profiles linked to nuclear factor-kappa B (NF-<i>κ</i>Β) and immune pathways. RNA sequencing of brain tissues showed that while LPS strongly elevated NF-<i>κ</i>Β and cytokine pathways, this effect was less pronounced in OFA-treated rats, indicating reduced LPS-driven inflammation at the transcriptome level. Overall, these findings highlight the potential of OFA extract, abundant in <i>β</i>-ionone and linalool, to mitigate inflammatory signaling and improve select metabolic markers in an LPS-induced inflammatory model.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"342-355"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147512836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mi Jeong Kim, Su Bin Lee, Dong Gun Park, Han-Hee Jo, Soonyeong Park, Jung-In Kim, Ji Youn Hong, Young Jun Kim, Bok Kyung Han
{"title":"Coffee Berry Pulp Extract Improves Hepatic Lipid Metabolism and Reduces Triglyceride Levels in High-Fat, High-Fructose Diet-Fed Mice.","authors":"Mi Jeong Kim, Su Bin Lee, Dong Gun Park, Han-Hee Jo, Soonyeong Park, Jung-In Kim, Ji Youn Hong, Young Jun Kim, Bok Kyung Han","doi":"10.1177/1096620X261441411","DOIUrl":"10.1177/1096620X261441411","url":null,"abstract":"<p><p>This study examined the effects of coffee berry pulp (CBP) extract on hepatic lipid accumulation and blood lipid levels in mice fed on a high-fat, high-fructose (HFHF) diet. Male C57BL/6J mice were divided into the following four groups and fed their respective diets for 15 weeks: normal diet, HFHF diet, and HFHF diet supplemented with 100 or 200 mg/kg body weight CBP extract. CBP inhibited weight gain and normalized blood glucose and insulin levels. CBP supplementation also inhibited lipid and lipoprotein accumulation in the liver, thereby effectively regulating triglyceride (TG) levels in both the blood and liver. Analysis of liver lipid metabolism revealed that CBP suppressed the increased messenger RNA (mRNA) expression of sterol regulatory element-binding protein-1C induced by HFHF and downregulated both mRNA and protein levels of peroxisome proliferator-activated receptor-γ. Liver X receptor regulation occurred at the mRNA level, and the adenosine monophosphate-activated protein kinase (AMPK)/phosphorylated AMPK ratio was modulated at the protein level. Among the lipid catabolic enzymes, adipose TG lipase expression was specifically modulated by CBP treatment. These findings suggest that CBP supplementation modulates key hepatic lipid regulators and reduces blood and liver TG accumulation. Although CBP shows promise in regulating TG synthesis and storage in a mouse model, further studies, including clinical validation, are required to confirm its potential as a treatment for human non-alcoholic fatty liver disease.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"364-372"},"PeriodicalIF":1.8,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147654236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Genetic Variation of Human Long-Chain Fatty Acyl-CoA Synthetase and Nutritional Implication.","authors":"So Young Bu","doi":"10.1177/1096620X261433056","DOIUrl":"10.1177/1096620X261433056","url":null,"abstract":"<p><p>Interindividual genetic differences influence the metabolism, absorption, and utilization of nutrients in various biological processes. In nutrition research, elucidating gene functions and understanding polymorphisms are essential for clarifying how genetic variations influence individual responses to diet, metabolism, and health outcomes. Long-chain fatty acyl-CoA synthetase (ACSL) catalyzes the conversion of long-chain fatty acids into acyl-CoA forms, which are channeled into multiple metabolic processes. Several isoforms of ACSL have been identified, each with unique metabolic properties. The functional characterization of ACSL has been extensively explored both <i>in vitro</i> and <i>in vivo</i> in recent years. These experimental investigations of gene functions may provide valuable information for human applications. This review summarizes <i>ACSL</i> polymorphisms reported to date and their functional implications. Most studies on human <i>ACSL</i> have employed genome-wide association studies, and each reported <i>ACSL</i> single-nucleotide polymorphism (SNP) has been associated with specialized functions, but the metabolic effects of <i>ACSL</i> SNPs were moderate or, in some traits, remain inconclusive. Yet, the direction of gene expression or function based on each ACSL variant has not been clearly indicated in existing genome-wide association studies' results. Thus, ACSL-based target mechanisms for nutrition intervention could not be specified. Further research should be conducted on studies that employ expression quantitative trait loci datasets, standardized nutrition assessment, and polygenic score approaches.</p>","PeriodicalId":16440,"journal":{"name":"Journal of medicinal food","volume":" ","pages":"294-311"},"PeriodicalIF":1.8,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147499084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}